openPR Logo
Press release

Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) announced

04-20-2020 10:56 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation on behalf of current long term investors in Geron Corporation (NASDAQ: GERN) shares.

An investigation was announced for current long-term investors in shares of Geron Corporation (NASDAQ: GERN) concerning potential breaches of fiduciary duties by certain directors and officers of Geron Corporation.

Investors who are current long term investors in Geron Corporation (NASDAQ: GERN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: GERN stocks follows a lawsuit filed against Geron Corporation over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: GERN stocks, concerns whether certain Geron directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District Court for the Northern District of California the plaintiff alleges that, the defendants: misled investors about the results of a clinical drug study of imetelstat called IMbark; and that as a result, defendants' statements about Geron's business, operations, and prospects were materially false and misleading and lacked a reasonable basis at all relevant times.

Those who purchased shares of Geron Corporation (NASDAQ: GERN) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Long-Term Investors in shares of Geron Corporation (NASDAQ: GERN) announced here

News-ID: 2017670 • Views: 707

More Releases from Shareholders Foundation

Investigation for Long-Term Investors in shares of PharmaCielo Ltd. (OTC: PCLOF) …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of PharmaCielo Ltd.. Investors who are current long term investors in PharmaCielo Ltd. (OTC: PCLOF) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in OTC: PCLOF stocks follows a lawsuit filed against PharmaCielo Ltd. over
Deadline on June 9th in Lawsuit for Investors in shares of ServiceMaster Global …
The Shareholders Foundation announced that a deadline is coming up on June 9, 2020 in the lawsuit filed for certain investors of ServiceMaster Global Holdings, Inc. (NYSE: SERV) over alleged securities laws violations by ServiceMaster Global Holdings, Inc. Investors who purchased shares of ServiceMaster Global Holdings, Inc. (NYSE: SERV) have certain options and there are strict and short deadlines running. Deadline: June 9, 2020. NYSE: SERV stockholders should contact the Shareholders
Investigation for Investors in shares of ProAssurance Corporation (NYSE: PRA) an …
An investigation was announced concerning potential securities laws violations by ProAssurance Corporation in connection with certain financial statements. Investors who purchased shares of ProAssurance Corporation (NYSE: PRA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by ProAssurance Corporation regarding its business, its prospects and its operations were materially false and
Lawsuit filed for Investors in EOS digital tokens offered by Block.one
An investor in EOS digital tokens offered by Block.one filed a lawsuit over alleged violations of Federal Securities Laws by Block.one Investors who purchased EOS digital tokens offered by Block.one have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The plaintiffs allege that June 26, 2017 through the present, Block.one and individuals Brendan Blumer and Dan Larimer promoted, offered, and sold an unregistered security

All 5 Releases


More Releases for Geron

Stem Cell Therapy Market Insights, Segment Forecast With Osiris Therapeutics, B …
The stem cell therapy market report is a scrupulous investigation of current scenario of the global market, which covers several market dynamics. With the use of up to date and proven tools and techniques, complex market insights are organized in simpler version in this stem cell therapy report for the better understanding of end user. This global stem cell therapy market research report is organized by collecting market research data
Stem Cell Therapy Market Insight, Business Intelligence With Osiris Therapeutics …
The purpose of this stem cell therapy report is to provide a telescopic view of current market trends, situations, opportunities and status as an information source established. In addition, all CAGR projections for 2016, 2017 base year and 2019-2026 forecast period are provided in stem cell therapy market report. Businesses can set inventive ideas and striking sales goals by drawing inspiration from rivals ' marketing strategies, which in turn will
Global Stem Cell Umbilical Cord Blood Market to 2019-2025| Advanced Cell Technol …
Researchmoz added Most up-to-date research on "Global Stem Cell Umbilical Cord Blood Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains
Myelofibrosis Therapeutics Pipeline 2017 - Key Players Analysis CTI BioPharma, G …
The study analysed that the therapeutics pipeline comprises of approximately 29 drug candidates in different stages of development. Myelofibrosis is a rare disorder in which excessive scar tissue gets formed in the bone marrow that impairs its ability to produce red blood cells. However, it is believed by researchers that myelofibrosis occurs due to the presence of abnormal red blood stem cells in the bone marrow. The abnormal blood stem cells
Stem Cell Market Recent Trends and Competitor Analysis | Astellas Pharma, Athers …
Stem Cell Market Overview: Humanity has lunged forward in the field of medical sciences by a huge margin. A riveting illustration of this is the theory of Stem Cells and its adoption into the Stem Cell therapy. Initial research by Ernest A McCulloch and James E Till at the University of Toronto, brought this very promising ally into the eyes of the world. Stem cells (Hematopoietic) are essentially discrete immature cells
Global Stem Cell Therapy Market Comprehensive 2018: BioTime, Osiris Therapeutics …
Stem cell therapy industry report contains explanation to what market definition, classifications, applications, engagements and market trends and also points at all the recent developments, product launches, joint ventures, merges and accusations by the several key players and brands that are driving the market whose company profiles are included in the report. Global stem cell therapy market 2018 research report is a proven source of information which offers a telescopic